Licensed in the UK for type 2 diabetes mellitus and chronic weight management in adults with obesity or overweight with comorbidities
Ozempic is the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes indicated not only to improve blood sugar, along with diet and exercise, but also to reduce the risk of major cardiovascular events (MACE) such as heart attack, stroke, or death in those who are also at high risk for these events
For example, in head-to-head discussions, analysts have noted that Mounjaros weight-loss results slightly outperformed Wegovys in comparable trials
Perspective: plant-based eating pattern for type 2 diabetes prevention and treatment: efficacy, mechanisms, and practical considerations
Role of NAD+ in regulating cellular and metabolic signaling pathways
Ozempic has joined that elite group where the brand name doesnt just sell the product its become synonymous with its entire category. Two-thirds of Americans now say they want to lose weight, Dan Frommer notes in his Consumer Trends deck for 2026